Biotech ETF Overview

With 16 ETFs traded in the U.S. markets, Biotech ETFs gather total assets under management of $19.06B. The average expense ratio is 0.69%. Biotech ETFs can be found in the following asset classes:

  • Equity

The largest Biotech ETF is the iShares NASDAQ Biotechnology ETF IBB with $9.23B in assets. In the last trailing year, the best performing Biotech ETF was the LABD at 203.56%. The most-recent ETF launched in the Biotech space was the Defiance NASDAQ Junior Biotechnology ETF IBBJ in 08/03/20.

Top ETF Performers

CNCR Loncar Cancer Immunotherapy ETF 9.22%
BBP Virtus LifeSci Biotech Products ETF 8.21%
IBBJ Defiance NASDAQ Junior Biotechnology ETF 8.06%
LABU Direxion Daily S&P Biotech Bull 3X Shares 4.74%
BBC Virtus LifeSci Biotech Clinical Trials ETF 3.17%

Bottom ETF Performers

LABD Direxion Daily S&P Biotech Bear 3X Shares -14.41%
GERM ETFMG Treatments Testing and Advancements ETF -10.02%
PBE Invesco Dynamic Biotechnology & Genome ETF -4.92%
GNOM Global X Genomics & Biotechnology ETF -4.46%
FBT First Trust NYSE Arca Biotechnology Index Fund -4.30%

Top Creations

PBE Invesco Dynamic Biotechnology & Genome ETF 34.83
LABU Direxion Daily S&P Biotech Bull 3X Shares 31.29
BBH VanEck Vectors Biotech ETF 8.11
GNOM Global X Genomics & Biotechnology ETF 8.00
IBBJ Defiance NASDAQ Junior Biotechnology ETF 2.50

Top Redemptions

XBI SPDR S&P Biotech ETF -284.46
IBB iShares NASDAQ Biotechnology ETF -244.94
FBT First Trust NYSE Arca Biotechnology Index Fund -47.06
LABD Direxion Daily S&P Biotech Bear 3X Shares -6.05
GERM ETFMG Treatments Testing and Advancements ETF -5.50

AUM Winners

GNOM Global X Genomics & Biotechnology ETF 12.98%
CNCR Loncar Cancer Immunotherapy ETF 9.51%
BBP Virtus LifeSci Biotech Products ETF 8.45%
IBBJ Defiance NASDAQ Junior Biotechnology ETF 8.35%
BIS ProShares UltraShort Nasdaq Biotechnology 8.32%

AUM Losers

GERM ETFMG Treatments Testing and Advancements ETF -24.66%
BBC Virtus LifeSci Biotech Clinical Trials ETF -9.99%
FBT First Trust NYSE Arca Biotechnology Index Fund -8.29%
BBH VanEck Vectors Biotech ETF -7.36%
PBE Invesco Dynamic Biotechnology & Genome ETF -6.21%

Features and News

Sleeper Hit ETF Of 2020

Global X's new telemedicine fund proves to be the right ETF for the right moment.

Podcasts

ETF Working Lunch: COVID A New Investment Factor

Joining us is Kristina Hooper, chief global market strategist at Invesco.

Daily ETF Watch

Junior Biotech ETF Debuts

New fund invests in small cap biotechnology stocks. 

ETF Strategist Corner

ETF Open To Close Ratio Jumps

An unusually high number of launches in June boosted the open-to-close ratio. 

Podcasts

ETF Prime Podcast: 2020 Halftime Report

Recapping ETFs at the halfway point of the year.

Features and News

Hot & Cold Health Care ETF Returns

Health care ETFs have diverged sharply as some stocks benefit from the pursuit of virus treatments, others not so much.

ETF.com Analysis

Biotech ETFs: Appraising The Pipelines

Parsing the performance and holdings of different biotech funds.

ETF.com Analysis

Thematic ETFs The New Sectors?

Sometimes an idea just gets you thinking about the possibilities.

ETF Report

Sectors In Review: May 2020

None of the sector ETFs managed to eke out a positive return during the month.